Quantification of the costs and benefits of various clinical trial flexibilities relied upon during the COVID-19 pandemic could help drive routine inclusion of some of these approaches, such as decentralized data collection and remote monitoring, into clinical trial protocols from the start.
Building such flexibilities into clinical trials at the outset could help make studies more resilient in the face of sudden...







